Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M UNGER

Showing results (571-580 of 604) with videos related to

Pageof 61
Sort By:
FEMS Microbiology Reviews|June 1, 1997
Applications of S-layersU B Sleytr, H Bayley, M Sára, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2019
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)Christine B Ambrosone, Gary R Zirpoli, Alan D Hutson, et al.
Journal of the National Cancer Institute|April 3, 2020
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With SurvivalRikki A Cannioto, Alan Hutson, Shruti Dighe, et al.
Journal of the National Cancer Institute|January 10, 2023
Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400IJoseph M Unger, Lu Qian, Mary W Redman, et al.
Blood|October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletionsLisa M Rimsza, Robin A Roberts, Elias Campo, et al.
The New England Journal of Medicine|November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaPatrick J Stiff, Joseph M Unger, James R Cook, et al.
Neurology|June 30, 2012
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control studyR B Postuma, J Y Montplaisir, A Pelletier, et al.
Journal of the National Cancer Institute|December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trialYara Abdou, William E Barlow, Julie R Gralow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical TrialsSarah C Rutherford, Jun Yin, Levi Pederson, et al.
Pageof 61

Showing results (571-580 of 604) with videos related to

Sort By:
Pageof 61
FEMS Microbiology Reviews|June 1, 1997
Applications of S-layersU B Sleytr, H Bayley, M Sára, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2019
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)Christine B Ambrosone, Gary R Zirpoli, Alan D Hutson, et al.
Journal of the National Cancer Institute|April 3, 2020
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With SurvivalRikki A Cannioto, Alan Hutson, Shruti Dighe, et al.
Journal of the National Cancer Institute|January 10, 2023
Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400IJoseph M Unger, Lu Qian, Mary W Redman, et al.
Blood|October 22, 2005
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletionsLisa M Rimsza, Robin A Roberts, Elias Campo, et al.
The New England Journal of Medicine|November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaPatrick J Stiff, Joseph M Unger, James R Cook, et al.
Neurology|June 30, 2012
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control studyR B Postuma, J Y Montplaisir, A Pelletier, et al.
Journal of the National Cancer Institute|December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trialYara Abdou, William E Barlow, Julie R Gralow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826Sharon M Castellino, Hongli Li, Alex F Herrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical TrialsSarah C Rutherford, Jun Yin, Levi Pederson, et al.
Pageof 61